(IN BRIEF) Sanofi has finalized its takeover of Vigil Neuroscience for roughly $470 million, acquiring all outstanding shares at $8 each and issuing a $2-per-share CVR tied to VG-3927’s first commercial sale. This deal, following Sanofi’s June 2024 strategic investment, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, Alzheimer’s disease, contingent value right, CVR, neurodegenerative research, Neurology, partnership, Phase 2 clinical study, preclinical pipeline, Sanofi, strategic investment, TREM2 agonist, VG-3927, VGL101, Vigil Neuroscience
(IN BRIEF) The University of Glasgow has appointed Professor Emma Thomson as the new Director of the MRC-University of Glasgow Centre for Virus Research (CVR), after she served as Interim Director from February. An expert in emerging infectious diseases, Professor … Read the full press release
Posted in Education, Healthcare, Science, Technology, United Kingdom
Tagged Centre for Virus Research, COVID-19, CVR, emerging viruses, Glasgow medical research, global health, hepatitis, infectious diseases, MRC, Pandemic Preparedness, Professor Emma Thomson, public health, scientific leadership, University of Glasgow, vaccine trials, viral research, virology
(IN BRIEF) After over a decade of leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini is stepping down as Director to take on the role of Head of Viroscience at Erasmus University Medical Centre in … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged apppointment, COVID-19, cross-species transmission, cryo-EM microscopes, CVR, drug-resistance screening hub, Ebola, Emerging Infectious Diseases, Erasmus University Medical Centre, global virus research, Head of Viroscience, hepatitis, human-animal interface, influenza, leadership, Medical Research Council, MRC, MRC-University of Glasgow Centre for Virus Research, Professor Emma Thomson, Professor Iain McInnes, Professor Massimo Palmarini, public health, University of Glasgow, vaccine trials, viral diseases, viral sequencing, virus pathogenesis, ZIKA
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?